世界のビバリルジン薬市場

QYResearchが発行した調査報告書(QYR8D01316)
◆英語タイトル:Global Bivalirudin Drug Industry Research Report, Growth Trends and Competitive Analysis 2018-2025
◆商品コード:QYR8D01316
◆発行会社(リサーチ会社):QYResearch
◆発行日:2018年11月(※2024年版があります。お問い合わせください。)
◆ページ数:112
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:食品・飲料
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,900 ⇒換算¥725,200見積依頼/購入/質問フォーム
Enterprise(同一法人内共有可)USD9,800 ⇒換算¥1,450,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートは、ビバリルジン薬のグローバル市場について調査・分析し、種類別には、溶解用パウダー、即使用可能溶液に、用途別には、病院、薬局に区分してまとめました。調査対象企業は、The Medicines Company、Sandoz、Fresenius Kabi、Pfizer、Mylan、Dr. Reddy's Laboratories、Apotex、Accord Healthcare、Aurobindo Pharma等です。

・レポートの概要
・グローバル成長トレンド
・ビバリルジン薬の世界市場規模
・ビバリルジン薬の地域別市場規模
・グローバル産業動向
・企業別市場シェア
・企業別ビバリルジン薬の価格動向
・ビバリルジン薬の種類別市場規模(溶解用パウダー、即使用可能溶液)
・ビバリルジン薬の用途別市場規模(病院、薬局)
・ビバリルジン薬の北米市場(アメリカ、カナダ、メキシコ)
・ビバリルジン薬のヨーロッパ市場(ドイツ、フランス、イギリス、イタリア、ロシア)
・ビバリルジン薬のアジア市場(日本、中国、韓国、インド、オーストラリア、インドネシア、タイ、マレーシア、フィリピン、ベトナム)
・ビバリルジン薬の中南米市場(ブラジル等)
・ビバリルジン薬の中東・アフリカ市場(GCC、エジプト、南アフリカ)
・主要企業情報(The Medicines Company、Sandoz、Fresenius Kabi、Pfizer、Mylan、Dr. Reddy's Laboratories、Apotex、Accord Healthcare、Aurobindo Pharma)
 -企業概要、事業概要、販売・売上・市場シェア、XXX製品概要、企業動向
・バリューチェーン及び販売チャネル分析
・ビバリルジン薬の市場規模予測
・ビバリルジン薬の種類別市場予測2018-2025(溶解用パウダー、即使用可能溶液)
・ビバリルジン薬の用途別市場予測2018-2025(病院、薬局)
・ビバリルジン薬の北米市場予測2018-2025(アメリカ、カナダ、メキシコ)
・ビバリルジン薬のヨーロッパ市場予測2018-2025(ドイツ、フランス、イギリス、イタリア、ロシア)
・ビバリルジン薬のアジア市場予測2018-2025(日本、中国、韓国、インド、オーストラリア、インドネシア、タイ、マレーシア、フィリピン、ベトナム)
・ビバリルジン薬の中南米市場予測2018-2025(ブラジル等)
・ビバリルジン薬の中東・アフリカ市場予測2018-2025(GCC、エジプト、南アフリカ)
・調査結果及び結論
【レポートの概要】

Bivalirudin (Angiomax or Angiox, manufactured by The Medicines Company) is a direct thrombin inhibitor (DTI).In 2018, the global Bivalirudin Drug market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. In this study, 2017 has been considered as the base year and 2018 to 2025 as the forecast period to estimate the market size for Bivalirudin Drug.

This study researches the market size of Bivalirudin Drug, presents the global Bivalirudin Drug sales and revenue by companies, regions, type and application, history breakdown data from 2013 to 2018, and forecast to 2025.
This report focuses on the key data information of Bivalirudin Drug in key regions like North America, Europe, Asia Pacific, Central & South America, and Middle East & Africa, presents sales, revenue, market share, growth rate of Bivalirudin Drug for each region and countries in each region.
For top companies, this report investigates and analyzes the sales, revenue, market share and growth rate for the top players, key data from 2013 to 2018.
This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter’s Five Forces Analysis.

This report includes the following manufacturers; we can also add the other companies as you want.
The Medicines Company
Sandoz
Fresenius Kabi
Pfizer
Mylan
Dr. Reddy’s Laboratories
Apotex
Accord Healthcare
Aurobindo Pharma

Market Segment by Product Type
Powder for reconstitution
Ready-to-use solution

Market Segment by Application
Hospital
Drug store

Market size split by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Egypt
South Africa

The study objectives are:
To analyze and research the global Bivalirudin Drug status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
To present the key Bivalirudin Drug manufacturers, capacity, production, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Bivalirudin Drug are as follows:
History Year: 2013-2018
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Research Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Bivalirudin Drug Market Size Growth Rate by Type
1.3.2 Powder for reconstitution
1.3.3 Ready-to-use solution
1.4 Market Segment by Application
1.4.1 Global Bivalirudin Drug Market Share by Application (2018-2025)
1.4.2 Hospital
1.4.3 Drug store
1.5 Study Objectives
1.6 Years Considered

2 Global Growth Trends
2.1 Global Bivalirudin Drug Market Size
2.1.1 Global Bivalirudin Drug Revenue 2013-2025
2.1.2 Global Bivalirudin Drug Sales 2013-2025
2.2 Bivalirudin Drug Growth Rate by Regions
2.2.1 Global Bivalirudin Drug Sales by Regions 2013-2018
2.2.2 Global Bivalirudin Drug Revenue by Regions 2013-2018
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers

3 Market Share by Manufacturers
3.1 Bivalirudin Drug Sales by Manufacturers
3.1.1 Bivalirudin Drug Sales by Manufacturers 2013-2018
3.1.2 Bivalirudin Drug Sales Market Share by Manufacturers 2013-2018
3.2 Revenue by Manufacturers
3.2.1 Bivalirudin Drug Revenue by Manufacturers (2013-2018)
3.2.2 Bivalirudin Drug Revenue Share by Manufacturers (2013-2018)
3.2.3 Global Bivalirudin Drug Market Concentration Ratio (CR5 and HHI)
3.3 Bivalirudin Drug Price by Manufacturers
3.4 Key Manufacturers Bivalirudin Drug Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Bivalirudin Drug Market
3.6 Key Manufacturers Bivalirudin Drug Product Offered
3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Powder for reconstitution Sales and Revenue (2013-2018)
4.1.2 Ready-to-use solution Sales and Revenue (2013-2018)
4.2 Global Bivalirudin Drug Sales Market Share by Type
4.3 Global Bivalirudin Drug Revenue Market Share by Type
4.4 Bivalirudin Drug Price by Type

5 Market Size by Application
5.1 Overview
5.2 Global Bivalirudin Drug Sales by Application

6 North America
6.1 North America Bivalirudin Drug Breakdown Data by Company
6.2 North America Bivalirudin Drug Breakdown Data by Type
6.3 North America Bivalirudin Drug Breakdown Data by Application
6.4 North America Bivalirudin Drug Breakdown Data by Countries
6.4.1 North America Bivalirudin Drug Sales by Countries
6.4.2 North America Bivalirudin Drug Revenue by Countries
6.4.3 United States
6.4.4 Canada
6.4.5 Mexico

7 Europe
7.1 Europe Bivalirudin Drug Breakdown Data by Company
7.2 Europe Bivalirudin Drug Breakdown Data by Type
7.3 Europe Bivalirudin Drug Breakdown Data by Application
7.4 Europe Bivalirudin Drug Breakdown Data by Countries
7.4.1 Europe Bivalirudin Drug Sales by Countries
7.4.2 Europe Bivalirudin Drug Revenue by Countries
7.4.3 Germany
7.4.4 France
7.4.5 UK
7.4.6 Italy
7.4.7 Russia

8 Asia Pacific
8.1 Asia Pacific Bivalirudin Drug Breakdown Data by Company
8.2 Asia Pacific Bivalirudin Drug Breakdown Data by Type
8.3 Asia Pacific Bivalirudin Drug Breakdown Data by Application
8.4 Asia Pacific Bivalirudin Drug Breakdown Data by Countries
8.4.1 Asia Pacific Bivalirudin Drug Sales by Countries
8.4.2 Asia Pacific Bivalirudin Drug Revenue by Countries
8.4.3 China
8.4.4 Japan
8.4.5 Korea
8.4.6 India
8.4.7 Australia
8.4.8 Indonesia
8.4.9 Malaysia
8.4.10 Philippines
8.4.11 Thailand
8.4.12 Vietnam

9 Central & South America
9.1 Central & South America Bivalirudin Drug Breakdown Data by Company
9.2 Central & South America Bivalirudin Drug Breakdown Data by Type
9.3 Central & South America Bivalirudin Drug Breakdown Data by Application
9.4 Central & South America Bivalirudin Drug Breakdown Data by Countries
9.4.1 Central & South America Bivalirudin Drug Sales by Countries
9.4.2 Central & South America Bivalirudin Drug Revenue by Countries
9.4.3 Brazil

10 Middle East and Africa
10.1 Middle East and Africa Bivalirudin Drug Breakdown Data by Type
10.2 Middle East and Africa Bivalirudin Drug Breakdown Data by Application
10.3 Middle East and Africa Bivalirudin Drug Breakdown Data by Countries
10.3.1 Middle East and Africa Bivalirudin Drug Sales by Countries
10.3.2 Middle East and Africa Bivalirudin Drug Revenue by Countries
10.3.3 GCC Countries
10.3.4 Egypt
10.3.5 South Africa

11 Company Profiles
11.1 The Medicines Company
11.1.1 The Medicines Company Company Details
11.1.2 Company Description and Business Overview
11.1.3 Sales, Revenue and Market Share of Bivalirudin Drug
11.1.4 Bivalirudin Drug Product Introduction
11.1.5 The Medicines Company Recent Development
11.2 Sandoz
11.2.1 Sandoz Company Details
11.2.2 Company Description and Business Overview
11.2.3 Sales, Revenue and Market Share of Bivalirudin Drug
11.2.4 Bivalirudin Drug Product Introduction
11.2.5 Sandoz Recent Development
11.3 Fresenius Kabi
11.3.1 Fresenius Kabi Company Details
11.3.2 Company Description and Business Overview
11.3.3 Sales, Revenue and Market Share of Bivalirudin Drug
11.3.4 Bivalirudin Drug Product Introduction
11.3.5 Fresenius Kabi Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Details
11.4.2 Company Description and Business Overview
11.4.3 Sales, Revenue and Market Share of Bivalirudin Drug
11.4.4 Bivalirudin Drug Product Introduction
11.4.5 Pfizer Recent Development
11.5 Mylan
11.5.1 Mylan Company Details
11.5.2 Company Description and Business Overview
11.5.3 Sales, Revenue and Market Share of Bivalirudin Drug
11.5.4 Bivalirudin Drug Product Introduction
11.5.5 Mylan Recent Development
11.6 Dr. Reddy’s Laboratories
11.6.1 Dr. Reddy’s Laboratories Company Details
11.6.2 Company Description and Business Overview
11.6.3 Sales, Revenue and Market Share of Bivalirudin Drug
11.6.4 Bivalirudin Drug Product Introduction
11.6.5 Dr. Reddy’s Laboratories Recent Development
11.7 Apotex
11.7.1 Apotex Company Details
11.7.2 Company Description and Business Overview
11.7.3 Sales, Revenue and Market Share of Bivalirudin Drug
11.7.4 Bivalirudin Drug Product Introduction
11.7.5 Apotex Recent Development
11.8 Accord Healthcare
11.8.1 Accord Healthcare Company Details
11.8.2 Company Description and Business Overview
11.8.3 Sales, Revenue and Market Share of Bivalirudin Drug
11.8.4 Bivalirudin Drug Product Introduction
11.8.5 Accord Healthcare Recent Development
11.9 Aurobindo Pharma
11.9.1 Aurobindo Pharma Company Details
11.9.2 Company Description and Business Overview
11.9.3 Sales, Revenue and Market Share of Bivalirudin Drug
11.9.4 Bivalirudin Drug Product Introduction
11.9.5 Aurobindo Pharma Recent Development

12 Value Chain and Sales Channels Analysis
12.1 Value Chain Analysis
12.2 Sales Channels Analysis
12.2.1 Bivalirudin Drug Sales Channels
12.2.2 Bivalirudin Drug Distributors
12.3 Bivalirudin Drug Customers

13 Market Forecast
13.1 Global Bivalirudin Drug Sales and Revenue Forecast 2018-2025
13.2 Global Bivalirudin Drug Sales Forecast by Type
13.3 Global Bivalirudin Drug Sales Forecast by Application
13.4 Bivalirudin Drug Forecast by Regions
13.4.1 Global Bivalirudin Drug Sales Forecast by Regions 2018-2025
13.4.2 Global Bivalirudin Drug Revenue Forecast by Regions 2018-2025
13.5 North America Market Forecast
13.5.1 North America Bivalirudin Drug Forecast by Countries 2018-2025
13.5.2 United States
13.5.3 Canada
13.5.4 Mexico
13.6 Europe Market Forecast
13.6.1 Europe Bivalirudin Drug Forecast by Countries 2018-2025
13.6.2 Germany
13.6.3 France
13.6.4 UK
13.6.5 Italy
13.6.6 Russia
13.7 Asia Pacific Market Forecast
13.7.1 Asia Pacific Bivalirudin Drug Sales Forecast by Countries 2018-2025
13.7.2 China
13.7.3 Japan
13.7.4 Korea
13.7.5 India
13.7.6 Australia
13.7.7 Indonesia
13.7.8 Thailand
13.7.9 Malaysia
13.7.10 Philippines
13.7.11 Vietnam
13.8 Central & South America Market Forecast
13.8.1 Central & South America Bivalirudin Drug Sales Forecast by Countries 2018-2025
13.8.2 Brazil
13.9 Middle East and Africa Market Forecast
13.9.1 Middle East and Africa Bivalirudin Drug Sales Forecast by Countries 2018-2025
13.9.2 GCC Countries
13.9.3 Egypt
13.9.4 South Africa

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer

...

【掲載企業】

The Medicines Company、Sandoz、Fresenius Kabi、Pfizer、Mylan、Dr. Reddy's Laboratories、Apotex、Accord Healthcare、Aurobindo Pharma

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のビバリルジン薬市場(Global Bivalirudin Drug Industry Research Report, Growth Trends and Competitive Analysis 2018-2025)]についてメールでお問い合わせはこちらでお願いします。